🚨Major Announcement🚨 CytexOrtho Receives FDA Approval for Revolutionary Hip Cartilage Repair Clinical Trial We're thrilled to announce that the FDA has approved our Investigational Device Exemption (IDE) application for the ReNew™ Hip Implant, clearing the path for our first-in-human clinical study. The ReNew Hip Implant represents a potential paradigm shift in the treatment of early stage osteoarthritis. Our bioabsorbable implant is designed to provide immediate structural support while promoting the body's natural healing process – offering hope for patients who are too young or active for traditional joint replacement. Thank you to our incredible team, partners, and supporters who have helped us reach this significant milestone. We look forward to beginning this important clinical study and working toward our mission of revolutionizing orthopedic care. 👉 Learn more about our technology and clinical trial: https://lnkd.in/e_tFEnmA #clinicaltrials #hip #cartilagerepair #regenerativemedicine #hipreplacement #hipresurfacing #venturecapital
CytexOrtho
生物技术研究
Durham,North Carolina 1,110 位关注者
Leading the way in regenerative medicine solutions for patients with damaged joint cartilage and osteoarthritis.
关于我们
CytexOrtho was formed to develop and commercialize the tissue regeneration technology discoveries coming out of the lab of Dr. Farshid Guilak at Duke University. The original Cytex business plan received numerous innovation awards, including seed capital for the startup phase. Since its founding, Cytex has gone on to win numerous state and federal grants, each recognizing the novelty of the research and its enormous potential contribution to the clinical management of patients with osteoarthritis. The three Cytex co-founders form the core leadership of the company as it continues to develop its novel products.
- 网站
-
https://cytexortho.com
CytexOrtho的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Durham,North Carolina
- 类型
- 私人持股
- 创立
- 2006
地点
-
主要
2609 North Duke St.
Suite #303A
US,North Carolina,Durham,27704
CytexOrtho员工
动态
-
CytexOrtho is honored to be part of MSK Innovations’ November 6th pitch event, showcasing groundbreaking technologies in musculoskeletal care! Our CEO and cofounder, Brad Estes, Ph.D., will present CytexOrtho's approach for treating early hip disease in a population with limited options. You'll also hear from Ofer Levy of ZygoFix Ltd., who will discuss their zLOCK system for spinal stabilization and Aditya Ingalhalikar, PhD, of INDIUS Medical Solutions, who will showcase their Patient Specific Growth Rods for pediatric scoliosis. 👉 You’re not going to want to miss this chance to hear about these exciting and innovative solutions. Register now: https://lnkd.in/gEP5fZzK #venturecapital #fundraising #orthopedics #orthopedicsurgery #medtech #hip #hippreservation
MSK Innovations is revolutionizing the way medical device startups connect with investors through intimate, curated "pitch events." Join them next month on November 6th to hear the latest from three companies and their innovations in MSK. November 6th Lineup: ZygoFix Ltd. - Ofer Levy, CEO ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system utilizes our spine’s natural anatomy for spinal stability. The system offers all around benefits to the $2.2 billion worldwide addressable spine market. CytexOrtho - Brad Estes, Ph.D., CEO CytexOrtho is developing an absorbable orthopedic implant designed to treat early hip disease in young/active patients, offering a much-needed solution for a growing population that currently lacks effective treatment options. INDIUS Medical Solutions - Aditya Ingalhalikar, PhD, CEO INDIUS has developed Patient Specific Growth Rods, an innovative solution for treating children with spinal scoliosis, reducing the need for multiple surgeries. INDIUS’s technology enables daily growth response, addressing a critical need in pediatric scoliosis care. The company holds global IP for this groundbreaking solution. Register today! https://lnkd.in/gEP5fZzK #venturecapital #seriesA #fundraising #orthopedics #orthopedicsurgery #scoliosis #medtech #spinesurgery Drue DeAngelis TJ Halvorson
-
-
If you're passionate about cutting-edge musculoskeletal innovation, the Musculoskeletal New Ventures Conference (MNVC) is an event you can't miss. Gary Stevenson, Mike Sherman, and Chris Lyons have crafted an incredible agenda for this year, with a fantastic lineup of companies, and CytexOrtho is excited to be part of it once again! Let’s make this year’s event the best one yet! #orthopedics #hip #regenerativemedicine #innovation #investor #medicaldevice #medtech #2024MNVC
The 22nd annual MNVC is just 3 weeks away. Check out the updated list of companies presenting this year. Register at www.mnvc.org. HealthpointCapital Mike Sherman Chris Lyons ABANZA Adjoint ALLUMIN8 Askel Healthcare Ltd BRINTER CurvaFix, Inc. CytexOrtho Empirical Spine, Inc Endeavor Orthopaedics, LLC INSURGICAL Powered Instruments Integrated Endoscopy meduloc MY01 Native Orthopaedics Onkos Surgical Osteal Therapeutics OTS Medical Reach Orthopaedics Inc. Reselute restor3d RevBio, Inc. Robossis SAIL Fusion Scalpel Spark Spine SteriCUBE® Shyamy Sastry Tesa Medical, Inc. TrackX Technology, Inc. VISIE Winter Innovations X-Bolt Orthopedics ZetrOZ Systems ZygoFix Ltd.
-
-
CytexOrtho转发了
MSK Innovations is excited to announce our lineup for November 6th's Pitch Event! ZygoFix Ltd. - Ofer Levy, CEO ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system utilizes our spine’s natural anatomy for spinal stability. The system offers all around benefits to the $2.2 billion worldwide addressable spine market. CytexOrtho - Brad Estes, Ph.D., CEO CytexOrtho is developing an absorbable orthopedic implant designed to treat early hip disease in young/active patients, offering a much-needed solution for a growing population that currently lacks effective treatment options. INDIUS Medical Solutions - Aditya Ingalhalikar, PhD, CEO INDIUS has developed Patient Specific Growth Rods, an innovative solution for treating children with spinal scoliosis, reducing the need for multiple surgeries. INDIUS’s technology enables daily growth response, addressing a critical need in pediatric scoliosis care. The company holds global IP for this groundbreaking solution. Register today! https://lnkd.in/gEP5fZzK #venturecapital #seriesA #fundraising #orthopedics #orthopedicsurgery #scoliosis #medtech #spinesurgery Drue DeAngelis TJ Halvorson
-
-
A big thank you to North Carolina Biotechnology Center (NCBiotech) for inviting CytexOrtho to present at #TriangleVentureDay yesterday at the Raleigh Convention Center! Our CEO, Brad Estes, Ph.D., had the privilege of presenting our exciting preclinical data, and we were thrilled to share the progress we’re making in developing technologies to renew joints and restore the lives of those affected by arthritis at a young age. And congratulations to the NC Biotechnology Center on their incredible 40-year anniversary—here’s to many more years of advancing life sciences in North Carolina! #osteoarthritis #hip #innovation #startups #venturecapital #orthopedics #medtech #regenerativemedicine
-
-
If you missed the 3DHEALS LLC event last week, check out an excerpt from our CEO, Brad Estes, Ph.D. discussing our implant design in Jenny Chen's post below. It's also not too late to check out the entire event! Great presentations and discussion all around from Y. Shrike Zhang, Flore-Anne Poujade, and Wilson Wong. See registration link below for details. #orthopedics #hipresurfacing #medicaldevices #regenerativemedicine #osteoarthritis
#THT #ThrowbackThursday Dr. Brad Estes, Ph.D. (Co-founder & CEO of CytexOrtho ) introduces #3D #woven #scaffold for #bone and #cartilage as the nextgen #medicaldevice #implants to meet unmet needs in #osteoarthritis #injury #hipreplacement Watch more on #Youtube: https://lnkd.in/gWfZasPk On-demand event registration: https://lnkd.in/gdbnDRa6
-
Don't miss the 3DHEALS LLC free event on "3D Bioprinting Biofabrication for Musculoskeletal Tissues" tomorrow (June 27) at 11:00 AM EDT, where CytexOrtho's CEO, Brad Estes, Ph.D., will be speaking on our approach to regenerating functional tissue in patients with early hip disease. Tomorrow's lineup features fantastic speakers: Flore-Anne Poujade from CELLINK, Wilson Wong from Novus Life Sciences Limited, and Y. Shrike Zhang from Harvard Medical School. This promises to be an exciting event, with deep conversations about the challenges, progress, and future of regenerative approaches to treat orthopedic disease. Don't miss it! Register here: https://lnkd.in/eWTakYr2 #orthopedics #regenerativemedicine #hipsurgery #3Dprinting #3dbioprinting #cartilagerepair #osteoarthritis
-
-
Be sure to tune in to "3D Bioprinting Biofabrication for Musculoskeletal Tissues" this Thursday. This is a free event put on by 3DHEALS LLC and Jenny Chen to discuss the rising demand for effective bone and cartilage repair/regeneration - this event promises to be a fantastic opportunity to discuss the many challenges and explore some of the innovative solutions being developed! Learn more about the event and its fantastic lineup of speakers, including Y. Shrike Zhang, Flore-Anne Poujade, Wilson Wong, and CytexOrtho's very own Brad Estes, Ph.D. at https://lnkd.in/eWTakYr2 #3dprinting #regenerativemedicine #hipsurgery #orthopedics #cartilagerepair #osteoarthritis
此处无法显示此内容
在领英 APP 中访问此内容等
-
If you haven't seen it yet, be sure to check out the new bioabsorbables polymers page at Medical Design & Outsourcing. It features insights into innovative materials and their applications, including a mention of CytexOrtho. Great overview Reed Miller and Jim Hammerand! #hipresurfacing #orthopedics #meddevice #hipreplacement #regenerativemedicine
Bioabsorbable, bioresorbable or just absorbable polymers — whatever you call them, these medical-grade materials are enabling implantable devices that disappear after the job is done. We've got a new bioabsorbable polymers page at Medical Design & Outsourcing, including an overview of different kinds of these polymers, applications from device developers such as Medtronic, Johnson & Johnson MedTech, Abbott, CytexOrtho and Elixir Medical Corporation, regulations and standards, and the challenges facing device designers and engineers who want to use them. Bioabsorbable materials experts should feel free to offer feedback in the comments or in an email or LinkedIn message to me and we'll add more technical guidance and tips in the months and years ahead. Thanks to Reed Miller for his work on this and CytexOrtho co-founder and CEO Brad Estes, Ph.D., for sharing some of his expertise.
-
CytexOrtho featured in Medical Design & Outsourcing! Great article Jim Hammerand! #hipresurfacing #orthopedics #meddevice #hipreplacement #AAOS #regenerativemedicine #clinicaltrials
CytexOrtho is using a unique three-dimensional weaving method and 3D printing to make fully bioabsorbable hip implants that could help younger patients delay or avoid hip replacements. Fresh off their OrthoPitch tech innovation competition win at #aaos2024, CytexOrtho co-founder and CEO Brad Estes, Ph.D., discussed the technology with Tom Salemi and Chris Newmarker. I've got the technical details of the ReNew Hip's design, development and manufacturing at Medical Design & Outsourcing:
CytexOrtho shares the 'secret sauce' for its absorbable hip implants
https://www.medicaldesignandoutsourcing.com